title: Long-term improvement of paroxysmal dystonic choreathetosis with acetazolamide.
authors.forename: Veronique
authors.initials: V
authors.lastname: Michel
authors.forename: Florence
authors.initials: F
authors.lastname: Riant
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Tournier-Lasserve
authors.forename: Dominique
authors.initials: D
authors.lastname: Guehl
authors.forename: Alain
authors.initials: A
authors.lastname: Lagueny
authors.forename: Bernard
authors.initials: B
authors.lastname: Bioulac
authors.forename: Pierre
authors.initials: P
authors.lastname: Burbaud
mesh_terms: D000086:Acetazolamide / Q000627:therapeutic use*; D000293:Adolescent; D001264:Athetosis / Q000188:drug therapy* / Q000235:genetics; D015220:Calcium Channels / Q000235:genetics; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D002819:Chorea / Q000188:drug therapy* / Q000235:genetics; D004421:Dystonia / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D008297:Male; D020864:Calcium Channels, N-Type
chemical_list: D000086:Acetazolamide; D015220:Calcium Channels; D002257:Carbonic Anhydrase Inhibitors; C105656:CACNA1A protein, human; D020864:Calcium Channels, N-Type